Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Degardin, M
Bastit, P
Rolland, F
Armand, JP
Chevallier, B
VanGlabbeke, M
Boudillet, J
Tresca, P
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：843 / 843
页数：1
相关论文
共 50 条
  • [11] A phase II study of vinorelbine GIRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Guillem, V
    Muñoz, MA
    Yaya, R
    Soriano, V
    Climent, MA
    Gaspar, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S176 - S176
  • [12] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tang, Patricia A.
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Pond, Gregory R.
    Johnson, Caitlin
    Colevas, A. Dimitrios
    Synold, Timothy W.
    Vasist, Lakshmi S.
    Winquist, Eric
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 257 - 264
  • [13] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [14] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Patricia A. Tang
    Lillian L. Siu
    Eric X. Chen
    Sebastien J. Hotte
    Stephen Chia
    James K. Schwarz
    Gregory R. Pond
    Caitlin Johnson
    A. Dimitrios Colevas
    Timothy W. Synold
    Lakshmi S. Vasist
    Eric Winquist
    Investigational New Drugs, 2008, 26 : 257 - 264
  • [15] Phase I study of gefitinib plus celecoxib in patients with metastatic and/or locally recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Wirth, LJ
    Haddad, RI
    Wieczorek, TJ
    Faucher, JL
    Clark, JR
    Norris, CM
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 498S - 498S
  • [16] A phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).
    Sabichi, A. L.
    Kies, M. S.
    Glisson, B. S.
    Lu, C.
    Ginsberg, L. E.
    Bartos, C. I.
    Feng, L.
    Tran, H. T.
    Lippman, S. M.
    Blumenschein, G. R., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [17] Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
    Hitt, R.
    Irigoyen, A.
    Nunez, J.
    Grau, J.
    Garcia Saenz, J.
    Pastor, M.
    Jara, C.
    Garcia Giron, C.
    Hidalgo, M.
    Cruz Hernandez, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [18] Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group phase II study
    Samlowski, Wolfram E.
    Moon, James
    Kuebler, J. Philip
    Nichols, Craig R.
    Gandara, David R.
    Ozer, Howard
    Williamson, Stephen K.
    Atkins, James N.
    Schuller, David E.
    Ensley, John F.
    CANCER INVESTIGATION, 2007, 25 (03) : 182 - 188
  • [19] Phase II study of capecitabine (X) plus reirradiation in patients (PTS) with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Kornek, Gabriela
    Vormittag, Laurenz
    Burian, Martin
    Radonjic, Dejan
    Selzer, Edgar
    ANNALS OF ONCOLOGY, 2006, 17 : 184 - 184
  • [20] Phase II study of capecitabine (X) plus reirradiation in patients (pts) with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Kornek, G.
    Burian, M.
    Vormittag, L.
    Radonjic, D.
    Selzer, E.
    EJC SUPPLEMENTS, 2005, 3 (02): : 295 - 295
12345